🔗 Permalink

Inventor profile of:

Solomon Langermann

City:

Baltimore, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-03-13

Top Assignees for applications by Solomon Langermann

The entities that hold a legal rights for patent applications filed by inventor Langermann Solomon:

AMPLIMMUNE, INC. 7 Gaithersburg, MD United States
MEDIMMUNE, LLC 7 Gaithersburg, MD United States
NEXTCURE, INC. 4 Beltsville, MD United States
THE JOHNS HOPKINS UNIVERSITY 3 Baltimore, MD United States
Amplimmune, Inc. 1 Rockville, MD United States
The John Hopkins University 1 Baltimore, MD United States
Washington University 1 St. Louis, MO United States
MEDIMMUNE, LLC 1 Gaitherburgh, MD United States
MEDIMMUNE, INC. 1 Gaithersburg, MD United States

Recent patent applications by Langermann Solomon

Solomon Langermann from Baltimore, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-13

US20250084164A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING LAIR SIGNAL TRANSDUCTION

#2 | 2023-11-09

US20230357384A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR MODULATING FLRT3 MEDIATED SIGNAL TRANSDUCTION

#3 | 2021-11-25

US20210363240A1

Chemistry; metallurgy

Compositions and methods for modulating LAIR signal transduction

#4 | 2021-02-04

US20210032346A1

Chemistry; metallurgy

B7-H4 antibodies and methods of use thereof

#5 | 2019-07-04

US20190202912A1

Chemistry; metallurgy

Antibodies for Siglec-15 and methods of use thereof

#6 | 2016-05-26

US20160146806A1

Physics

RECEPTORS FOR B7-H4

#7 | 2016-05-12

US20160130348A1

Chemistry; metallurgy

ANTIBODIES AND OTHER MOLECULES THAT BIND B7-H1 AND PD-1

#8 | 2016-04-07

US20160096891A1

Chemistry; metallurgy

Anti-B7-H5 antibodies and their uses

#9 | 2016-02-11

US20160039906A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR THE INHIBITION OF TRANSPLANT REJECTION

#10 | 2016-02-11

US20160039905A1

Chemistry; metallurgy

B7-H4 fusion proteins and methods of use thereof

#11 | 2016-01-28

US20160024210A1

Chemistry; metallurgy

Anti-H7CR antibodies

#12 | 2015-11-05

US20150315275A1

Chemistry; metallurgy

Anti-human B7-H4 antibodies and their uses

#13 | 2014-12-04

US20140356364A1

Chemistry; metallurgy

Anti-B7-H4 antibodies and their uses

#14 | 2014-08-14

US20140227262A1

Human necessities

PD-1 Antagonists and Methods for Treating Infectious Disease

#15 | 2014-02-13

US20140044738A1

Chemistry; metallurgy

Antibodies and other molecules that bind B7-H1 and PD-1

#16 | 2013-09-05

US20130230514A1

Human necessities

COMPOSITIONS OF PD-1 ANTAGONISTS AND METHODS OF USE

#17 | 2013-01-17

US20130017199A1

Human necessities

SIMULTANEOUS INHIBITION OF PD-L1/PD-L2

#18 | 2012-11-01

US20120276095A1

Chemistry; metallurgy

B7-H4 fusion proteins and methods of use thereof

#19 | 2012-07-12

US20120177645A1

Chemistry; metallurgy

Methods and compositions for the inhibition of transplant rejection

#20 | 2012-05-10

US20120114649A1

Human necessities

Compositions of PD-1 antagonists and methods of use

#21 | 2012-05-10

US20120114648A1

Human necessities

Compositions of PD-1 antagonists and methods of use

#22 | 2011-09-15

US20110223188A1

Human necessities

TARGETED COSTIMULATORY POLYPEPTIDES AND METHODS OF USE TO TREAT CANCER

#23 | 2011-08-11

US20110195068A1

Human necessities

PD-1 ANTAGONISTS AND METHODS OF USE THEREOF

#24 | 2011-06-30

US20110159023A1

Human necessities

PD-1 ANTAGONISTS AND METHODS FOR TREATING INFECTIOUS DISEASE

#25 | 2010-11-04

US20100278838A1

Chemistry; metallurgy

EPHA2 MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

#26 | 2010-03-04

US20100055102A1

Human necessities

Compositions of PD-1 antagonists and methods of use

#27 | 2009-06-25

US20090162933A1

Chemistry; metallurgy

EPHA2 AND HYPERPROLIFERATIVE CELL DISORDERS

#28 | 2007-07-19

US20070166314A1

Chemistry; metallurgy

EpA2 monoclonal antibodies and methods of use thereof

#29 | 2005-09-08

US20050196408A1

Chemistry; metallurgy

Method of administering FimH protein as a vaccine for urinary tract infections

#30 | 2005-08-11

US20050175616A1

Chemistry; metallurgy

PCDGF receptor antibodies and methods of use thereof

#31 | 2005-07-05

US10027350

Therapeutic compounds structurally-linked to bacterial polypeptides

#32 | 2005-03-17

US20050059592A1

Chemistry; metallurgy

EphA2 and hyperproliferative cell disorders

#33 | 2005-03-03

US20050049176A1

Chemistry; metallurgy

EphA2, hypoproliferative cell disorders and epithelial and endothelial reconstitution

InventorID:

40198 ⎘